Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey

doi:10.12998/wjcc.v11.i20.4865

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2040)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

990

Tables (1-4)

280

Sum=1356

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

119

Download

481

Sum=600

Jul 16, 2023 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Cases. Jul 16, 2023; 11(20): 4865-4873
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4865

Table 4 Ranking of participants’ reasons for not reporting adverse drug reactions

Reason	% (Ratio)
Difficulty in deciding whether ADRs have occurred	54 (320/592)
Insufficient time to report ADR	52 (312/592)
Consideration that the ADR is not significant enough to be reported	46 (275/592)
The absence of any reward for reporting	45 (270/592)
Believing that licensed drugs are safe	43 (255/592)
The notion that a single unreported ADR will not affect the database	41 (247/592)
Not knowing how to make a notification	34 (203/592)

ADR: Adverse drug reactions.

Citation: Aydin OC, Aydin S, Guney HZ. Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey. World J Clin Cases 2023; 11(20): 4865-4873
URL: https://www.wjgnet.com/2307-8960/full/v11/i20/4865.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i20.4865